384 related articles for article (PubMed ID: 10540325)
1. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.
Issazadeh S; Navikas V; Schaub M; Sayegh M; Khoury S
J Immunol; 1998 Aug; 161(3):1104-12. PubMed ID: 9686568
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of acute passive murine encephalomyelitis II. Th1 phenotype of the inducing population is not sufficient to cause disease.
Lyons JA; Zhao ML; Fritz RB
J Neuroimmunol; 1999 Jan; 93(1-2):26-36. PubMed ID: 10378866
[TBL] [Abstract][Full Text] [Related]
4. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis.
Perrin PJ; Scott D; June CH; Racke MK
Immunol Res; 1995; 14(3):189-99. PubMed ID: 8778209
[TBL] [Abstract][Full Text] [Related]
5. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
6. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis.
Cross AH; Ku G
J Neuroimmunol; 2000 Oct; 110(1-2):76-82. PubMed ID: 11024536
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
Orima K; Yamazaki K; Aoyagi T; Hara K
Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Davis TA; Gray GS; Doggett MJ; Abe R; June CH; Racke MK
J Neuroimmunol; 1996 Mar; 65(1):31-9. PubMed ID: 8642061
[TBL] [Abstract][Full Text] [Related]
10. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
[TBL] [Abstract][Full Text] [Related]
11. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
[TBL] [Abstract][Full Text] [Related]
12. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease.
Karandikar NJ; Vanderlugt CL; Bluestone JA; Miller SD
J Neuroimmunol; 1998 Aug; 89(1-2):10-8. PubMed ID: 9726820
[TBL] [Abstract][Full Text] [Related]
13. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
14. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
16. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
Chang TT; Kuchroo VK; Sharpe AH
Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
[No Abstract] [Full Text] [Related]
17. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28.
Srinivasan M; Gienapp IE; Stuckman SS; Rogers CJ; Jewell SD; Kaumaya PT; Whitacre CC
J Immunol; 2002 Aug; 169(4):2180-8. PubMed ID: 12165548
[TBL] [Abstract][Full Text] [Related]
18. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC
Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078
[TBL] [Abstract][Full Text] [Related]
19. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.
Wagner DH; Hagman J; Linsley PS; Hodsdon W; Freed JH; Newell MK
J Exp Med; 1996 Nov; 184(5):1631-8. PubMed ID: 8920853
[TBL] [Abstract][Full Text] [Related]
20. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
Neville KL; Dal Canto MC; Bluestone JA; Miller SD
J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
